srijeda, 13.04.2011.
TERMINAL CANCER.
The role of nutritional support as an
adjunct to managing cancer patients, not just those with
incurable disease, has long been a subject of discussion and
opinion. Ten years ago,Casinň Online italiani a review of the status of nutritional
support in cancer patients concluded that with the possible
exception of bone marrow transplantation, no benefit had
been documented for any outcome parameter, including
survival. In 1997 Samuel Klein summarized a conference
sponsored by the National Institutes of Health (NIH) and
two nutrition societies, which concluded that at least shortterm
enteral or parenteral support does not decrease mortality
or complications in cancer patients receiving cancer
therapy; no good trials of long-term support were available
to analyze. The conference further noted that while one
might expect nutritional support to improve quality of life,
no data existed that demonstrated this. Although no trials
have specifically addressed terminal cancer patients there is
consensus that artificial nutrition would not be beneficial.
"
